Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-021060
Filing Date
2010-03-04
Accepted
2010-03-04 17:06:06
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y83067e10vk.htm 10-K 958952
2 EX-21.A y83067exv21wa.htm EX-21.A 853
3 EX-23.A y83067exv23wa.htm EX-23.A 1388
4 EX-31.A y83067exv31wa.htm EX-31.A 6016
5 EX-31.B y83067exv31wb.htm EX-31.B 6404
6 EX-32.A y83067exv32wa.htm EX-32.A 2925
7 EX-32.B y83067exv32wb.htm EX-32.B 2998
8 EX-99.1 y83067exv99w1.htm EX-99.1 81343
10 GRAPHIC y83067y8306700.gif GRAPHIC 18473
11 GRAPHIC y83067y8306701.gif GRAPHIC 7836
  Complete submission text file 0000950123-10-021060.txt   1098907
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 10657900
SIC: 2834 Pharmaceutical Preparations